Fundz

Reprise Biomedical, Inc. reported raising $2.78 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATENov 25, 2020$2.8M of $5M raised

Amount Raised

$2.78 Million

$2.78 Million sold, per SEC Form D (first sale Nov 25, 2020)

Round Type

Venture

PlymouthBiotechnology

Quick answer

Reprise Biomedical raised $2.78 Million in a funding round, dated November 25, 2020. Reprise Biomedical is based in Plymouth, Minnesota, United States.

How much did Reprise Biomedical raise?
Reprise Biomedical raised $2.78 Million in a funding round on November 25, 2020.
What does Reprise Biomedical do?
Reprise Biomedical, Inc. is focused on the development and commercialization of biological medical devices which offer advanced solutions for healing.
Where is Reprise Biomedical based and how big is it?
Reprise Biomedical is based in Plymouth, Minnesota, United States. Fundz records about 45 employees.
Who are the decision-makers at Reprise Biomedical?
Fundz holds 2 contacts at Reprise Biomedical, including the Vice President of Sales. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Reprise Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • MicrobeDx, Inc. raised $300K (Seed) on January 8, 2021.
  • Cellectar raised $20M on January 8, 2021.
  • Intus Bio raised $330K on January 8, 2021.
  • XENTER raised $2.8M (Seed) on January 8, 2021.
  • Vitaltechhub INC raised an undisclosed amount on January 8, 2021.
  • Rocket One raised $5M on January 8, 2021.

Who to call at Reprise Biomedical, and when

A new round usually means Reprise Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Reprise Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Reprise Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Reprise Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Reprise Biomedical

Location

17400 Medina Rd., Ste. 100

Plymouth, Minnesota, United States

About

Reprise Biomedical, Inc. is focused on the development and commercialization of biological medical devices which offer advanced solutions for healing. Reprise was established as a spin-off from Miromatrix Medical Inc. in July 2019 and took ownership of the manufacturing, marketing, and distribution for two commercially available products, MiroDerm biologic wound matrix and MiroFlex biologic matrix for soft tissue reinforcement. The company is committed to innovation using our proprietary perfusion decellularization technology to develop new medical devices which address unmet surgical needs for healing. Our newest product, Miro3D wound matrix, is an example of that commitment. Miro3D broadens our wound management portfolio by offering a unique three-dimensional solution for deep and tunneling wounds.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Reprise Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsTina W., Vice President of Sales hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Reprise Biomedical's next move

See what Strategic adds

Reprise Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.